BATS BZX Real-Time Price
As of 3:30pm ET
| -0.69 / -3.93%|
The 7 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 25.00, with a high estimate of 31.00 and a low estimate of 7.00. The median estimate represents a +48.37% increase from the last price of 16.85.
The current consensus among 7 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.